AOD-9604 5mg

$39.99

  • Compound: AOD-9604
  • Amount: 5mg
  • Vial Size: 3mL
  • Sequence: H-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr-OH
  • Molecular Weight: 1815.12 g/mol
  • Supplied PubChem CID: 16131447*
  • CAS Number: 386264-39-7
  • Acetic Acid Required: No
  • Compatibility Notice: Do not mix with sodium chloride
  • Recommended Solution: OROS Reconstitution Solution
  • Intended Use: Controlled laboratory research only

50 in stock

Description

AOD-9604 5mg – Powerful Peptide Research Material

AOD-9604 5mg is a peptide research material supplied in a 3mL vial with a documented sequence, molecular weight, and chemical identifiers. According to the supplied product specifications, acetic acid is not required for laboratory reconstitution, and OROS Reconstitution Solution is recommended.

Important compatibility notice: DO NOT MIX WITH SODIUM CHLORIDE.

The supplied molecular weight is 1815.12 g/mol, the stated PubChem CID is 16131447, and the CAS number is 386264-39-7.

*The supplied PubChem hyperlink points to compound 16132341 rather than the stated CID 16131447. This discrepancy should be independently verified before publishing a definitive compound-specific PubChem link.

AOD-9604 5mg Research Overview

The supplied product specifications are:

Specification Product Information
Compound AOD-9604
Amount 5mg
Vial Size 3mL
Sequence H-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr-OH
Molecular Weight 1815.12 g/mol
Supplied PubChem CID 16131447*
CAS Number 386264-39-7
Acetic Acid Required No
Sodium Chloride Do not mix

No molecular formula was included in the supplied specifications, so a formula is not being inferred or added to this product description.

The 5mg amount and 3mL vial capacity are product specifications and do not establish a human dose or experimental concentration.

AOD-9604 Sequence and Molecular Specifications

The supplied sequence for AOD-9604 is:

H-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr-OH

The supplied molecular weight is:

1815.12 g/mol

The stated CAS number is 386264-39-7, while the supplied PubChem CID is 16131447.

However, the PubChem URL provided with that identifier points to compound 16132341. Because the stated identifier and hyperlink conflict, the URL should not be treated as definitive verification of the supplied CID until independently checked.

AOD 9604 Research Identification

Researchers may encounter the compound written as aod 9604, AOD-9604, or other punctuation variations.

Search formatting should not replace precise research identification.

For this product, relevant supplied characteristics include:

  • Defined peptide sequence
  • 5mg material quantity
  • 1815.12 g/mol molecular weight
  • Supplied PubChem CID 16131447
  • CAS number 386264-39-7
  • 3mL vial capacity
  • Specific laboratory compatibility information

These specifications provide multiple reference points for documentation and comparison with relevant research records.

A.O.D 9604 Search Terminology

The phrase a.o.d 9604 has significant search activity in the supplied keyword research.

It represents a punctuation variation that researchers may encounter when searching for information about the material.

For scientific documentation, consistent compound naming and molecular identification are preferable to relying on keyword variations alone. Researchers should compare sequence, molecular weight, identifiers, product format, and applicable preparation specifications when evaluating research materials.

What Is AOD-9604?

The phrase what is aod-9604 represents informational search intent.

For purposes of this product page, AOD-9604 is the designated peptide research material supplied at 5mg in a 3mL vial with the sequence and molecular characteristics documented above.

This page does not infer therapeutic properties, clinical outcomes, or human-use applications from the compound name. Research conclusions should instead be based on appropriately designed studies and relevant scientific literature.

Peptide AOD 9604 Research Context

The phrase peptide aod 9604 may also appear in scientific and commercial searches.

For controlled laboratory investigation, researchers should focus on experiment-specific variables such as:

  • Material identity
  • Peptide sequence
  • Research model
  • Experimental concentration
  • Sample preparation
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Observation period
  • Measured endpoints
  • Reproducibility

These variables are more relevant to experimental interpretation than keyword formatting.

AOD-9604 Reconstitution Compatibility

The supplied laboratory preparation information for AOD-9604 is specific:

Acetic acid is not required for reconstitution.

For laboratory preparation, OROS Reconstitution Solution is recommended.

DO NOT MIX WITH SODIUM CHLORIDE.

Researchers should preserve these product-specific compatibility requirements rather than assuming that solvents or preparation conditions used with other research materials are interchangeable.

No additional solvent compatibility, final concentration, stability, or preparation-volume information was supplied, so those parameters are not being inferred.

AOD-9604 5mg Research Format

This AOD-9604 product contains 5mg of specified research material.

The amount describes the quantity supplied and should not be interpreted as a human dose, injection amount, treatment quantity, or recommended experimental concentration.

The material is supplied in a 3mL vial. Vial capacity describes the physical container and does not independently determine preparation volume or concentration.

Laboratory Research Documentation

Researchers working with this material may document:

Compound: AOD-9604
Amount: 5mg
Sequence: H-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr-OH
Molecular Weight: 1815.12 g/mol
Supplied PubChem CID: 16131447
CAS Number: 386264-39-7
Vial Capacity: 3mL
Acetic Acid Required: No
Sodium Chloride: Do not mix

Experiment-specific documentation can separately include research concentration, model, controls, preparation conditions, analytical procedures, observation period, and measured endpoints.

Evaluating AOD-9604 Research

When reviewing research involving AOD-9604, investigators should determine whether the material and experimental conditions correspond to those relevant to their own work.

Important comparison factors can include:

  • Exact molecular identity
  • Peptide sequence
  • Material format
  • Experimental concentration
  • Research model
  • Study design
  • Controls
  • Preparation conditions
  • Analytical methodology
  • Observation period
  • Experimental endpoints

Results generated under one experimental system should not automatically be generalized to another.

Related OROS Research Materials

Researchers can review OR-3R 5mg as a separately specified research material.

Additional OR-3R strengths include OR-3R 10mg and OR-3R 20mg.

The catalog also includes an OR-3R 10mg / Elora 5mg formulation. No URL was supplied for that product, so a product link has not been invented.

Each research material should be identified and documented according to its own supplied specifications.

Scientific Research Resources

Researchers can use PubChem to investigate available molecular records and chemical identifiers.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

Because the supplied AOD-9604 PubChem CID and hyperlink conflict, the appropriate compound-specific database record should be independently verified before incorporating it into definitive research documentation.

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is the peptide research material described on this page. The supplied product contains 5mg of material in a 3mL vial with a documented sequence and molecular weight of 1815.12 g/mol.

What is the AOD-9604 sequence?

The supplied sequence is H-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-Tyr-OH.

What is the molecular weight?

The supplied molecular weight is 1815.12 g/mol.

Is acetic acid required for reconstitution?

No. According to the supplied product specifications, acetic acid is not required for reconstitution.

Can AOD-9604 be mixed with sodium chloride?

No. The supplied compatibility information specifically states: DO NOT MIX WITH SODIUM CHLORIDE.

What reconstitution solution is recommended?

For controlled laboratory preparation, the supplied recommendation is OROS Reconstitution Solution.

What is the PubChem CID?

The supplied PubChem CID is 16131447. However, the accompanying hyperlink points to compound 16132341, so the identifier/link combination should be independently verified.

What size vial is supplied?

The material is supplied in a 3mL vial. Vial capacity does not independently determine experimental concentration or preparation volume.

Research Use Disclaimer

This AOD-9604 5mg material is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantity, vial capacity, and compatibility information are laboratory product specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, weight loss, athletic performance enhancement, bodybuilding, or veterinary application.

Additional information
Net Weight

5mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “AOD-9604 5mg”

Your email address will not be published. Required fields are marked *